- Home
- KXIN vs IBIO Comparison
KXIN vs IBIO Comparison
Compare KXIN & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KXIN
- IBIO
- Stock Information
- Founded
- KXIN 2015
- IBIO 2008
- Country
- KXIN China
- IBIO United States
- Employees
- KXIN N/A
- IBIO N/A
- Industry
- KXIN Retail-Auto Dealers and Gas Stations
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- KXIN Consumer Discretionary
- IBIO Health Care
- Exchange
- KXIN Nasdaq
- IBIO Nasdaq
- Market Cap
- KXIN 10.4M
- IBIO 11.9M
- IPO Year
- KXIN N/A
- IBIO N/A
- Fundamental
- Price
- KXIN $0.78
- IBIO $0.66
- Analyst Decision
- KXIN
- IBIO Strong Buy
- Analyst Count
- KXIN 0
- IBIO 2
- Target Price
- KXIN N/A
- IBIO $5.50
- AVG Volume (30 Days)
- KXIN 144.3K
- IBIO 532.9K
- Earning Date
- KXIN 01-01-0001
- IBIO 09-19-2025
- Dividend Yield
- KXIN N/A
- IBIO N/A
- EPS Growth
- KXIN N/A
- IBIO N/A
- EPS
- KXIN N/A
- IBIO N/A
- Revenue
- KXIN N/A
- IBIO $375,000.00
- Revenue This Year
- KXIN N/A
- IBIO $81.33
- Revenue Next Year
- KXIN N/A
- IBIO N/A
- P/E Ratio
- KXIN N/A
- IBIO N/A
- Revenue Growth
- KXIN N/A
- IBIO 650.00
- 52 Week Low
- KXIN $0.64
- IBIO $0.64
- 52 Week High
- KXIN $29.54
- IBIO $6.89
- Technical
- Relative Strength Index (RSI)
- KXIN 36.20
- IBIO 33.40
- Support Level
- KXIN $0.81
- IBIO $0.71
- Resistance Level
- KXIN $0.85
- IBIO $0.78
- Average True Range (ATR)
- KXIN 0.06
- IBIO 0.03
- MACD
- KXIN -0.01
- IBIO -0.00
- Stochastic Oscillator
- KXIN 27.21
- IBIO 6.43
About KXIN Kaixin Auto Holdings
Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.